These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18783531)

  • 101. Differences between pre- and postmenopausal women in cues for sexual desire.
    McCall K; Meston C
    J Sex Med; 2007 Mar; 4(2):364-71. PubMed ID: 17367431
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Female sexual dysfunction: Drug treatment options].
    Alcántara Montero A; Sánchez Carnerero CI
    Semergen; 2016; 42(5):e33-7. PubMed ID: 27041639
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR; Allgood A; Auerbach P; Eubank D; Greist J; Bharmal M; Zipfel L; Guo CY
    J Sex Med; 2010 Feb; 7(2 Pt 2):917-27. PubMed ID: 19832932
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Drugs in early clinical development for the treatment of female sexual dysfunction.
    Belkin ZR; Krapf JM; Goldstein AT
    Expert Opin Investig Drugs; 2015 Feb; 24(2):159-67. PubMed ID: 25376023
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Hypoactive sexual desire disorder in postmenopausal women.
    Nappi RE; Wawra K; Schmitt S
    Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Sexual desire, distress, and associated factors in premenopausal women: preliminary findings from the hypoactive sexual desire disorder registry for women.
    Connor MK; Maserejian NN; De Rogatis L; Meston CM; Gerstenberger EP; Rosen RC
    J Sex Marital Ther; 2011; 37(3):176-89. PubMed ID: 21512938
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Attitudinal survey of women living with low sexual desire.
    Kingsberg SA
    J Womens Health (Larchmt); 2014 Oct; 23(10):817-23. PubMed ID: 25105910
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Medical Treatment of Female Sexual Dysfunction.
    Nappi RE; Tiranini L; Martini E; Bosoni D; Righi A; Cucinella L
    Urol Clin North Am; 2022 May; 49(2):299-307. PubMed ID: 35428435
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
    Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
    van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Low libido in postmenopausal women.
    McKinney LN
    Adv Nurse Pract; 2007 Jan; 15(1):28-35; quiz 36. PubMed ID: 19998672
    [No Abstract]   [Full Text] [Related]  

  • 114. Use of Testosterone in Postmenopausal Women.
    Davis SR
    Endocrinol Metab Clin North Am; 2021 Mar; 50(1):113-124. PubMed ID: 33518180
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 116. [Hypoactive sexual desire disorder].
    Przybylski M; Spaczyński M
    Ginekol Pol; 2009 Jul; 80(7):518-22. PubMed ID: 19697816
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Effect of a multi-ingredient based food supplement on sexual function in women with low sexual desire.
    Palacios S; Soler E; Ramírez M; Lilue M; Khorsandi D; Losa F
    BMC Womens Health; 2019 Apr; 19(1):58. PubMed ID: 31039769
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Testosterone for low libido.
    Basson R
    N Engl J Med; 2009 Feb; 360(7):728; author reply 728-9. PubMed ID: 19213689
    [No Abstract]   [Full Text] [Related]  

  • 119. Managing low sexual desire in women.
    Maclaran K; Panay N
    Womens Health (Lond); 2011 Sep; 7(5):571-81; quiz 582-3. PubMed ID: 21879825
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.